119 related articles for article (PubMed ID: 8607900)
1. Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements.
Bradbeer JN; Kapadia RD; Sarkar SK; Zhao H; Stroup GB; Swift BA; Rieman DJ; Badger AM
Arthritis Rheum; 1996 Mar; 39(3):504-14. PubMed ID: 8607900
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.
Badger AM; Griswold DE; Kapadia R; Blake S; Swift BA; Hoffman SJ; Stroup GB; Webb E; Rieman DJ; Gowen M; Boehm JC; Adams JL; Lee JC
Arthritis Rheum; 2000 Jan; 43(1):175-83. PubMed ID: 10643714
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.
Badger AM; Blake S; Kapadia R; Sarkar S; Levin J; Swift BA; Hoffman SJ; Stroup GB; Miller WH; Gowen M; Lark MW
Arthritis Rheum; 2001 Jan; 44(1):128-37. PubMed ID: 11212150
[TBL] [Abstract][Full Text] [Related]
4. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
5. Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis.
Badger AM; Blake SM; Dodds RA; Griswold DE; Swift BA; Rieman DJ; Stroup GB; Hoffman SJ; Gowen M
J Pharmacol Exp Ther; 1999 Dec; 291(3):1380-6. PubMed ID: 10565864
[TBL] [Abstract][Full Text] [Related]
6. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
Campagnuolo G; Bolon B; Feige U
Arthritis Rheum; 2002 Jul; 46(7):1926-36. PubMed ID: 12124878
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
Koufany M; Chappard D; Netter P; Bastien C; Weryha G; Jouzeau JY; Moulin D
Arthritis Rheum; 2013 Dec; 65(12):3084-95. PubMed ID: 23982996
[TBL] [Abstract][Full Text] [Related]
9. Disease modifying effects of N-butyryl glucosamine in a streptococcal cell wall induced arthritis model in rats.
Wang SX; Cherian A; Dumitriu M; Grynpas MD; Carran J; Wainman D; Anastassiades T
J Rheumatol; 2007 Apr; 34(4):712-20. PubMed ID: 17309122
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
11. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
Francis MD; Hovancik K; Boyce RW
Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progression.
Badger AM; Swift BA; Webb EF; Clark RK; Bugelski PJ; Griswold DE
Int J Immunopharmacol; 1993 Apr; 15(3):343-52. PubMed ID: 8505147
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
Koufany M; Jouzeau JY; Moulin D
Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
[TBL] [Abstract][Full Text] [Related]
15. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein.
Bush KA; Farmer KM; Walker JS; Kirkham BW
Arthritis Rheum; 2002 Mar; 46(3):802-5. PubMed ID: 11920418
[TBL] [Abstract][Full Text] [Related]
16. A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat.
Jacobson PB; Morgan SJ; Wilcox DM; Nguyen P; Ratajczak CA; Carlson RP; Harris RR; Nuss M
Arthritis Rheum; 1999 Oct; 42(10):2060-73. PubMed ID: 10524677
[TBL] [Abstract][Full Text] [Related]
17. Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis.
Yamane I; Hagino H; Okano T; Enokida M; Yamasaki D; Teshima R
Arthritis Rheum; 2003 Jun; 48(6):1732-41. PubMed ID: 12794842
[TBL] [Abstract][Full Text] [Related]
18. Antiinflammatory and chondroprotective effects of the aminobisphosphonate incadronate (YM175) in adjuvant induced arthritis.
Matsuo A; Shuto T; Hirata G; Satoh H; Matsumoto Y; Zhao H; Iwamoto Y
J Rheumatol; 2003 Jun; 30(6):1280-90. PubMed ID: 12784404
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic activity of SK&F 105685, a novel azaspirane with suppressor-cell inducing activity.
Badger AM; Swift BA
Clin Exp Rheumatol; 1993; 11 Suppl 8():S107-9. PubMed ID: 8324933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
